Skip to main content
. 2020 Dec 22;11:6435. doi: 10.1038/s41467-020-20143-x

Fig. 1. Anti-tryptase antibody E104 inhibits β-tryptase in biochemical and cell-based assays.

Fig. 1

a Concentration-dependent inhibition of βI-tryptase enzymatic activity in the presence of heparin by rabbit (rab) E104, rabbit-human chimeric (ch) E104 IgG1 and E104 IgG4. b Humanized E104.v1 and E104.v2 IgG1 show concentration-dependent inhibition of βI-tryptase enzymatic activity, but E104.v1 loses its inhibitory activity at higher concentrations (hook effect). c Primary human bronchial smooth muscle cell (BSMC) proliferation stimulated by βI-tryptase, which is inhibited by anti-tryptase humanized E104.v2 IgG4 in a concentration-dependent manner. d Primary human smooth muscle cell contraction is induced by βI-tryptase, which is inhibited by humanized E104.v2 IgG4. Data is represented as mean ± s.d. (n = 3 biologically independent experiments; a, b and n = 4 biologically independent experiments; c, d). Graphs were created using Kaleidagraph v4.1.3. Source data are provided as a Source Data file.